Cellectar Biosciences
CLRB
CLRB
37 hedge funds and large institutions have $28.3M invested in Cellectar Biosciences in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $36.3M → $28.3M (-$8.08M)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
95% less call options, than puts
Call options by funds: $8K | Put options by funds: $151K
Holders
37
Holding in Top 10
2
Calls
$8K
Puts
$151K
Top Buyers
| 1 | +$5.21M | |
| 2 | +$932K | |
| 3 | +$523K | |
| 4 |
BlackRock
New York
|
+$216K |
| 5 |
Morgan Stanley
New York
|
+$155K |
Top Sellers
| 1 | -$552K | |
| 2 | -$414K | |
| 3 | -$392K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$182K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$178K |